Prostate cancer therapy (laser plus TOOKAD Soluble) invented at Israel’s Weizmann Institute completed Phase 3 trials on 480 patients in Latin America and Europe and was approved by Mexico’s health authority. Minimal side-effects were associated with the high cure rates.

http://wis-wander.weizmann.ac.il/press-releases/tookad-soluble